|
|
|
|
LEADER |
01000cam a2200265 4500 |
001 |
1623873711 |
003 |
DE-627 |
005 |
20230427062222.0 |
007 |
tu |
008 |
020403s2001 xx ||||| m 00| ||eng c |
020 |
|
|
|a 9155449069
|9 91-554-4906-9
|
035 |
|
|
|a (DE-627)1623873711
|
035 |
|
|
|a (DE-576)09805564X
|
035 |
|
|
|a (DE-599)BSZ09805564X
|
035 |
|
|
|a (OCoLC)59492826
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Alterman, Mathias
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Design and synthesis of HIV-1 protease inhibitors
|c by Mathias Alterman
|
264 |
|
1 |
|a Uppsala
|b Univ., Faculty of Pharmacy
|c 2001
|
300 |
|
|
|a 70 S.
|b graph. Darst.
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
490 |
1 |
|
|a Acta Universitatis Upsaliensis
|a Comprehensive summaries of Uppsala dissertations from the Faculty of Pharmacy
|v 245
|
502 |
|
|
|a Zugl.: Uppsala, Univ., Diss., 2001
|
583 |
1 |
|
|a Archivierung prüfen
|c 20200919
|f DE-640
|z 1
|2 pdager
|
655 |
|
7 |
|a Hochschulschrift
|0 (DE-588)4113937-9
|0 (DE-627)105825778
|0 (DE-576)209480580
|2 gnd-content
|
751 |
|
|
|a Uppsala
|0 (DE-588)4078659-6
|0 (DE-627)106076744
|0 (DE-576)209209488
|4 uvp
|
810 |
2 |
|
|a Uppsala Universitet
|b Farmaceutiska Fakulteten
|t Comprehensive summaries of Uppsala dissertations from the Faculty of Pharmacy
|v 245
|9 245
|w (DE-627)129583227
|w (DE-576)017406641
|w (DE-600)233135-4
|x 0282-7484
|7 ns
|
912 |
|
|
|a GBV_ILN_2021
|
912 |
|
|
|a ISIL_DE-289
|
912 |
|
|
|a SYSFLAG_1
|
912 |
|
|
|a GBV_KXP
|
912 |
|
|
|a SSG-OLC-PHA
|
951 |
|
|
|a BO
|
980 |
|
|
|2 2021
|1 01
|x DE-289
|b 3253506959
|c 00
|f W
|d H 209.094
|e --%%--
|j --%%--
|y l01
|z 03-04-02
|